Merck & Co. (MRK)
(Delayed Data from NYSE)
$108.61 USD
-1.40 (-1.27%)
Updated Jun 7, 2023 04:03 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Top 25% (62 out of 250)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.44 | 2.10 | 9.99 |
Current Quarter Estimate | 1.85 | 37.64 | 53.00 |
Year Ago Quarter Estimate | 1.87 | 11.39 | 49.36 |
Next Quarter Estimate | 1.98 | 34.85 | 55.00 |
Next Year Estimate | 8.46 | 178.47 | 250.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -7.09 | 0.20 | 8.78 |
Next Year | 21.73 | 10.90 | 16.69 |
Last 5 Years | 13.00 | 9.60 | 9.00 |
Next 5 Years | 8.30 | 14.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 16.11 | 15.53 |
Price/Book (MRQ) | 5.88 | 5.92 |
Price/Cash Flow (MRFY) | 12.02 | 12.26 |
Dividend Yield | 2.69% | 2.63% |
Net Profit Margin (TTM) | 22.52% | 15.41% |
Return on Equity (TTM) | 37.92% | 36.13% |
Debt to Equity (MRQ) | 0.60 | 37.44 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.